Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 5, 2004, Pages 1241-1246

  Gui, C Y ^a   Ngo, L ^a   Xu, W S ^a   Richon, V M ^b   Marks, P A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Aton Pharma Inc   (United States)

Author keywords

Multiple myeloma; Myc; RNA polymerase; Suberoylanilide hydroxamic acid

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; EPSILON GLOBIN; GLOBIN; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; MYC PROTEIN; PROTEIN P21; PROTEIN P27; PROTEIN P27 KIPI; RNA POLYMERASE II; UNCLASSIFIED DRUG; VORINOSTAT;

ACETYLATION; ARTICLE; CELL STRAIN; CELL STRAIN ARP 1; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; PROTEIN MODIFICATION;

ACETYLATION; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DEOXYRIBONUCLEASE I; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; PROMOTER REGIONS (GENETICS); PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 0842277812     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0307708100     Document Type: Article

References (46)

1. Felsenfeld, G. & Groudine, M. (2003) Nature 421, 448-453.
2. Spotswood, H. T. & Turner, B. M. (2002) J. Clin. Invest. 110, 577-582.
3. Jenuwein, T. & Allis, C. D. (2001) Science 293, 1074-1080.
4. Zhang, Y. & Reinberg, D. (2001) Genes Dev. 15, 2343-2360.
5. Allfrey, V. G. (1966) Proc. Can. Cancer Conf. 6, 313-335.
6. Johnson, C. A. & Turner, B. M. (1999) Semin. Cell. Dev. Biol. 10, 179-188.
7. Khochbin, S., Verdel, A., Lemercier, C. & Seigneurin-Berny, D. (2001) Curr. Opin. Genet. Dev. 11, 162-166.
8. Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T. & Kelly, W. K. (2001) Nat. Rev. Cancer 1, 194-202.
9. Roth, S. Y., Denu, J. M. & Allis, C. D. (2001) Annu. Rev. Biochem. 70, 81-120.
10. Strahl, B. D. & Allis, C. D. (2000) Nature 403, 41-45.
11. Turner, B. M. (2000) Bioessays 22, 836-845.
12. Agalioti, T., Chen, G. & Thanos, D. (2000) Cell 111, 381-392.
13. Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A. & Marks, P. A. (1996) Proc. Natl. Acad. Sci. USA 93, 5705-5708.
14. Yoshida, M., Kijima, M., Akita, M. & Beppu, T. (1990) J. Biol. Chem. 265, 17174-17179.
15. Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R. & Pavletich, N. P. (1999) Nature 401, 188-193.
16. Van Lint, C., Emiliani, S. & Verdin, E. (1996) Gene Expr. 5, 245-253.
17. Richon, V. M., Sandhoff, T. W., Rifkind, R. A. & Marks, P. A. (2000) Proc. Natl. Acad. Sci. USA 97, 10014-10019.
18. Vrana, J. A., Decker, R. H., Johnson, C. R., Wang, Z., Jarvis, W. D., Richon, V. M., Ehinger, M., Fisher, P. B. & Grant, S. (1999) Oncogene 18, 7016-7025.
19. Xiao, H., Hasegawa, T. & Isobe, K. (1999) J. Cell. Biochem. 73, 291-302.
20. Butler, L. M., Zhou, X., Xu, W.-S., Scher, H. I., Rifkind, R. A., Marks, P. A. & Richon, V. M. (2002) Proc. Natl. Acad. Sci. USA 99, 11700-11705.
21. Huang, L., Sowa, Y., Sakai, T. & Pardee, A. B. (2000) Oncogene 19, 5712-5719.
22. Sambucetti, L. C., Fischer, D. D., Zabludoff, S., Kwon, P. O., Chamberlin, H., Trogani, N., Xu, H. & Cohen, D. (1999) J. Biol. Chem. 274, 34940-34947.
23. Sowa, Y., Orita, T., Minamikawa, S., Nakano, K., Mizuno, T., Nomura, H. & Sakai, T. (1997) Biochem. Biophys. Res. Commun. 241, 142-150.
24. Orphanides, G. & Reinberg, D. (2000) Nature 407, 471-475.
25. Belotserkovskaya, R., Oh, S., Bondarenko, V. A., Orphanides, G., Studitsky, V. M. & Reinberg, D. (2003) Science 301, 1090-1093.
26. Grozinger, C. M. & Schreiber, S. L. (2002) Chem. Biol. 9, 3-16.
27. de Ruijter, A. J., van Gennip, A. H., Caron, H. N., Kemp, S. & van Kuilenburg, A. B. (2003) Biochem. J. 370, 737-749.
28. Marks, P. A., Miller, T. & Richon, V. M. (2003) Curr. Opin. Pharmacol. 3, 344-351.
29. Lagger, G., O'Carroll, D., Rembold, M., Khier, H., Tischler, J., Weitzer, G., Schuettengruber, B., Hauser, C., Brunmeir, R., Jenuwein, T. & Seiser, C. (2002) EMBO J. 21, 2672-2681.
30. Cress, W. D. & Seto, E. (2000) J. Cell Physiol. 184, 1-16.
31. Timmermann, S., Lehrmann, H., Polesskaya, A. & Harel-Bellan, A. (2001) Cell Mol. Life Sci. 58, 728-736.
32. Wang, C., Fu, M., Mani, S., Wadler, S., Senderowicz, A. M. & Pestell, R. G. (2001) Front. Biosci. 6, D610-D629.
33. Jones, P. A. & Baylin, S. B. (2002) Nat. Rev. Genet. 3, 415-428.
34. Qiu, L., Kelso, M. J., Hansen, C., West, M. L., Fairlie, D. P. & Parsons, P. G. (1999) Br. J. Cancer 80, 1252-1258.
35. Kelly, W. K., O'Connor, O. A. & Marks, P. A. (2002) Exp. Opin. Invest. Drugs 11, 1695-1713.
36. Kelly, W. K., Richon, V. M., O'Connor, O., Curley, T., MacGregor-Curtelli, B., Tong, W., Klang, M., Schwartz, L., Richardson, S., Rosa, E., et al. (2003) Clin. Cancer Res. 9, 3578-3588.
37. Siegel, D. S., Zhang, X., Feinman, R., Teitz, T., Zelenetz, A., Richon, V. M., Rifkind, R. A., Marks, P. A. & Michaeli, J. (1998) Proc. Natl. Acad. Sci. USA 95, 162-166.
38. Butler, L. M., Agus, D. B., Scher, H. I., Higgins, B., Rose, A., Cordon-Cardo, C., Thaler, H. T., Rifkind, R. A., Marks, P. A. & Richon, V. M. (2000) Cancer Res. 60, 5165-5170.
39. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Lab. Press, Plainview, NY), 2nd Ed., pp. 18.60-18.75.
40. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A. & Struhl, K. (1998) Current Protocols in Molecular Biology (Wiley, New York), pp. 12.1.1-12.1.6.
41. Gui, C. Y. & Dean, A. (2001) Mol. Cell. Biol. 21, 1155-1163.
42. Gui, C. Y. & Dean, A. (2003) Proc. Natl. Acad. Sci. USA 100, 7009-7014.
43. Munster, P. N., Troso-Sandoval, T., Rosen, N., Rifkind, R. A., Marks, P. A. & Richon, V. M. (2001) Cancer Res. 61, 8492-8497.
44. Fischle, W., Wang, Y. & Allis, C. D. (2003) Nature 425, 475-479.
45. Seoane, J., Le, H. V. & Massague, J. (2002) Nature 419, 729-734.
46. Johnstone, R. W. (2002) Nat. Rev. Drug Discov. 1, 287-299.